03 January 2019 10:15 CET

Karo Intressenter AB publishes supplement to offer document regarding its public cash offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

19 January 2022
EQT AB (publ) Year-end Report 2021
18 January 2022
EQT sets target fund size of EQT X at EUR 20 billion
17 January 2022
Zorro Bidco holds a total of 97 percent in zooplus after completion of the public delisting tender offer – zooplus shares delisted from Frankfurt Stock Exchange among others
07 January 2022
EQT Private Equity exits CFB Group, a multi-brand food and beverage platform operator
05 January 2022
Invitation to presentation of EQT AB’s Year-end Report 2021